Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy A Rassen

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
JAMA|January 8, 2009
Outcomes in the era of bare-metal stents vs the era of drug-eluting stentsJeremy A Rassen, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety|January 21, 2012
Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance systemJeremy A Rassen, Sebastian Schneeweiss
Journal of Comparative Effectiveness Research|November 19, 2013
Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analysesJeremy A Rassen, Sebastian Schneeweiss
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2012
Emerging analytical techniques for comparative effectiveness researchSteven M Brunelli, Jeremy A Rassen
Diabetes, Obesity & Metabolism|February 10, 2021
Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in biasJeremy A Rassen, William Murk, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety|February 18, 2010
Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databasesJeremy A Rassen, Jerry Avorn, Sebastian Schneeweiss
Diabetes, Obesity & Metabolism|April 14, 2021
Reply to the Letter by Arterburn D. et al. ("Bias in EHR-based studies: Seeing the Forest for the Trees")Jeremy A Rassen, William Murk, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety|April 1, 2010
Instrumental variable methods in comparative safety and effectiveness researchM Alan Brookhart, Jeremy A Rassen, Sebastian Schneeweiss
Epidemiology (Cambridge, Mass.)|July 31, 2014
Optimal matching ratios in drug safety surveillanceShirley V Wang, Sebastian Schneeweiss, Jeremy A Rassen
Epidemiology (Cambridge, Mass.)|June 30, 2018
Erratum: High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataRichard Wyss, Bruce Fireman, Jeremy A Rassen, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
JAMA|January 8, 2009
Outcomes in the era of bare-metal stents vs the era of drug-eluting stentsJeremy A Rassen, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety|January 21, 2012
Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance systemJeremy A Rassen, Sebastian Schneeweiss
Journal of Comparative Effectiveness Research|November 19, 2013
Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analysesJeremy A Rassen, Sebastian Schneeweiss
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 2, 2012
Emerging analytical techniques for comparative effectiveness researchSteven M Brunelli, Jeremy A Rassen
Diabetes, Obesity & Metabolism|February 10, 2021
Real-world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in biasJeremy A Rassen, William Murk, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety|February 18, 2010
Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databasesJeremy A Rassen, Jerry Avorn, Sebastian Schneeweiss
Diabetes, Obesity & Metabolism|April 14, 2021
Reply to the Letter by Arterburn D. et al. ("Bias in EHR-based studies: Seeing the Forest for the Trees")Jeremy A Rassen, William Murk, Sebastian Schneeweiss
Pharmacoepidemiology and Drug Safety|April 1, 2010
Instrumental variable methods in comparative safety and effectiveness researchM Alan Brookhart, Jeremy A Rassen, Sebastian Schneeweiss
Epidemiology (Cambridge, Mass.)|July 31, 2014
Optimal matching ratios in drug safety surveillanceShirley V Wang, Sebastian Schneeweiss, Jeremy A Rassen
Epidemiology (Cambridge, Mass.)|June 30, 2018
Erratum: High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataRichard Wyss, Bruce Fireman, Jeremy A Rassen, et al.
Pageof 8